Roche Holding AG
SIX:ROG
Roche Holding AG
Total Current Liabilities
Roche Holding AG
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Total Current Liabilities
CHf24.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
Novartis AG
SIX:NOVN
|
Total Current Liabilities
$29.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
2%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Total Current Liabilities
$3.4m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Total Current Liabilities
$7.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Total Current Liabilities?
Total Current Liabilities
24.8B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Total Current Liabilities amounts to 24.8B CHF.
What is Roche Holding AG's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
5%
Over the last year, the Total Current Liabilities growth was -9%. The average annual Total Current Liabilities growth rates for Roche Holding AG have been -1% over the past three years , 2% over the past five years , and 5% over the past ten years .